Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 239

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Malignant Melanoma S3‐Guideline “Diagnosis, Therapy and Follow‐up of Melanoma”

Open access
Pflugfelder, Annette, Kochs, Corinna, Blum, Andreas, Capellaro, Marcus, Czeschik, Christina, Dettenborn, Therese, Dill, Dorothee, Dippel, Edgar, Eigentler, Thomas, Feyer, Petra, Follmann, Markus, Frerich, Bernhard, Ganten, Maria‐Katharina, Gärtner, Jan, Gutzmer, Ralf, Hassel, Jessica, Hauschild, Axel, Hohenberger, Peter, Hübner, Jutta, Kaatz, Martin, Kleeberg, Ulrich R., Kölbl, Oliver, Kortmann, Rolf‐Dieter, Krause‐Bergmann, Albrecht, Kurschat, Peter, Leiter, Ulrike, Link, Hartmut, Loquai, Carmen, Löser, Christoph, Mackensen, Andreas, Meier, Friedegund, Mohr, Peter, Möhrle, Matthias, Nashan, Dorothee, Reske, Sven, Rose, Christian, Sander, Christian, Satzger, Imke, Schiller, Meinhard, Schlemmer, Heinz‐Peter, Strittmatter, Gerhard, Sunderkötter, Cord, Swoboda, Lothar, Trefzer, Uwe, Voltz, Raymond, Vordermark, Dirk, Weichenthal, Michael, Werner, Andreas, Wesselmann, Simone, Weyergraf, Ansgar J., Wick, Wolfgang, Garbe, Claus, Schadendorf, Dirk·2013·JDDG: Journal der Deutschen Dermatologischen Gesellschaft
DOI 10.1111/ddg.12113_suppl
Open this paper in CoChat — free account

Abstract

This first German evidence-based guideline for cutaneous melanoma was developed under the auspices of the German Dermatological Society (DDG) and the Dermatologic Cooperative Oncology Group (DeCOG) and funded by the German Guideline Program in Oncology. The recommendations are based on a systematic literature search, and on the consensus of 32 medical societies, working groups and patient representatives. This guideline contains recommendations concerning diagnosis, therapy and follow-up of melanoma. The diagnosis of primary melanoma based on clinical features and dermoscopic criteria. It is confirmed by histopathologic examination after complete excision with a small margin. For the staging of melanoma, the AJCC classification of 2009 is used. The definitive excision margins are 0.5 cm for in situ melanomas, 1 cm for melanomas with up to 2 mm tumor thickness and 2 cm for thicker melanomas, they are reached in a secondary excision. From 1 mm tumor thickness, sentinel lymph node biopsy is recommended. For stages II and III, adjuvant therapy with interferon-alpha should be considered after careful analysis of the benefits and possible risks. In the stage of locoregional metastasis surgical treatment with complete lymphadenectomy is the treatment of choice. In the presence of distant metastasis mutational screening should be performed for BRAF mutation, and eventually for CKIT and NRAS mutations. In the presence of mutations in case of inoperable metastases targeted therapies should be applied. Furthermore, in addition to standard chemotherapies, new immunotherapies such as the CTLA-4 antibody ipilimumab are available. Regular follow-up examinations are recommended for a period of 10 years, with an intensified schedule for the first three years.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/ddg.12113_suppl

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Cited by

See all 239

Metadata

Authors
Pflugfelder, A., Kochs, C., Blum, A., Capellaro, M., Czeschik, C., Dettenborn, T., Dill, D., Dippel, E., Eigentler, T., Feyer, P., Follmann, M., Frerich, B., Ganten, M., Gärtner, J., Gutzmer, R., Hassel, J., Hauschild, A., Hohenberger, P., Hübner, J., Kaatz, M., Kleeberg, U. R., Kölbl, O., Kortmann, R., Krause‐Bergmann, A., Kurschat, P., Leiter, U., Link, H., Loquai, C., Löser, C., Mackensen, A., Meier, F., Mohr, P., Möhrle, M., Nashan, D., Reske, S., Rose, C., Sander, C., Satzger, I., Schiller, M., Schlemmer, H., Strittmatter, G., Sunderkötter, C., Swoboda, L., Trefzer, U., Voltz, R., Vordermark, D., Weichenthal, M., Werner, A., Wesselmann, S., Weyergraf, A. J., Wick, W., Garbe, C., & Schadendorf, D.
Venue
JDDG: Journal der Deutschen Dermatologischen Gesellschaft
Publisher
Wiley
Published
2013-08
Volume
11
Issue
s6
Pages
1-116
ISSN
  • 1610-0379 (ISSN-L)
  • 1610-0387
DOI
10.1111/ddg.12113_suppl
OpenAlex
W1482307014
Cited by
239
References
13
FWCI
16.44
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Malignant Melanoma S3‐Guideline “Diagnosis, Therapy and Follow‐up of Melanoma”. https://app.cochat.ai/papers/10.1111/ddg.12113_suppl
The paper
Pflugfelder, A., Kochs, C., Blum, A., Capellaro, M., Czeschik, C., Dettenborn, T., Dill, D., Dippel, E., Eigentler, T., Feyer, P., Follmann, M., Frerich, B., Ganten, M., Gärtner, J., Gutzmer, R., Hassel, J., Hauschild, A., Hohenberger, P., Hübner, J., . . . Schadendorf, D. (2013). Malignant Melanoma S3‐Guideline “Diagnosis, Therapy and Follow‐up of Melanoma”. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. https://doi.org/10.1111/ddg.12113_suppl

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.